NCT06363123View on ClinicalTrials.gov

Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis

RecruitingOBSERVATIONAL
Enrollment

2,700

Participants

Timeline

Start Date

March 29, 2024

Primary Completion Date

October 31, 2024

Study Completion Date

April 30, 2025

Conditions
Lung CancerBreast CancerColorectal CancerThyroid CancerGastric CancerCervical CancerLiver CancerPancreatic CancerCholangiocarcinomaProstate CancerEsophageal CancerOvarian CancerRenal Cell Carcinoma
Trial Locations (4)

100021

RECRUITING

Cancer Hospital Chinese Academy of Medical Sciences, Beijing

100050

RECRUITING

Beijing Friendship Hospital, Capital Medical University, Beijing

310022

RECRUITING

Zhejiang Cancer Hospital, Hangzhou

050010

RECRUITING

Hebei Tumor Hospital, Shijiazhuang

All Listed Sponsors
lead

Beijing Friendship Hospital

OTHER